Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation

Figure 4

Toxic function evaluation in cancer EVs. The graph represents the Ingenuity Pathway results, providing the related Downstream Regulator analysis of proteins detected in cancer EVs.